Patents by Inventor Theodore Standiford

Theodore Standiford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMER PARTICLES FOR NEUTROPHIL INJURY
    Publication number: 20240197638
    Abstract: Provided herein are methods of treatment, compositions, systems and kits using polymer particles as restraints of neutrophil function. Such methods include, but are not limited to, methods of preventing, treating, and/or ameliorating inflammatory diseases, infections, autoimmune diseases, malignant diseases, and other diseases or conditions in which neutrophils may be implicated. In some embodiments, polymer particles are useful for diagnosing neutrophil related diseases or conditions.
    Type: Application
    Filed: November 27, 2023
    Publication date: June 20, 2024
    Inventors: Omolola Eniola-Adefeso, William Kelley, Theodore Standiford
  • Polymer particles for neutrophil injury
    Patent number: 11826469
    Abstract: Provided herein are methods of treatment, compositions, systems and kits using polymer particles as restraints of neutrophil function. Such methods include, but are not limited to, methods of preventing, treating, and/or ameliorating inflammatory diseases, infections, autoimmune diseases, malignant diseases, and other diseases or conditions in which neutrophils may be implicated. In some embodiments, polymer particles are useful for diagnosing neutrophil related diseases or conditions.
    Type: Grant
    Filed: September 22, 2021
    Date of Patent: November 28, 2023
    Assignee: The Regents of the University of Michigan
    Inventors: Omolola Eniola-Adefeso, William Kelley, Theodore Standiford
  • Polymer particles for neutrophil injury
    Patent number: 11376221
    Abstract: Provided herein are methods of treatment, compositions, systems and kits using polymer particles as restraints of neutrophil function. Such methods include, but are not limited to, methods of preventing, treating, and/or ameliorating inflammatory diseases, infections, autoimmune diseases, malignant diseases, and other diseases or conditions in which neutrophils may be implicated. In some embodiments, polymer particles are useful for diagnosing neutrophil related diseases or conditions.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: July 5, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Omolola Eniola-Adefeso, William Kelley, Theodore Standiford
  • POLYMER PARTICLES FOR NEUTROPHIL INJURY
    Publication number: 20220071908
    Abstract: Provided herein are methods of treatment, compositions, systems and kits using polymer particles as restraints of neutrophil function. Such methods include, but are not limited to, methods of preventing, treating, and/or ameliorating inflammatory diseases, infections, autoimmune diseases, malignant diseases, and other diseases or conditions in which neutrophils may be implicated. In some embodiments, polymer particles are useful for diagnosing neutrophil related diseases or conditions.
    Type: Application
    Filed: September 22, 2021
    Publication date: March 10, 2022
    Inventors: Omolola Eniola-Adefeso, William Kelley, Theodore Standiford
  • POLYMER PARTICLES FOR NEUTROPHIL INJURY
    Publication number: 20210000745
    Abstract: Provided herein are methods of treatment, compositions, systems and kits using polymer particles as restraints of neutrophil function. Such methods include, but are not limited to, methods of preventing, treating, and/or ameliorating inflammatory diseases, infections, autoimmune diseases, malignant diseases, and other diseases or conditions in which neutrophils may be implicated. In some embodiments, polymer particles are useful for diagnosing neutrophil related diseases or conditions.
    Type: Application
    Filed: July 2, 2020
    Publication date: January 7, 2021
    Inventors: Omolola Eniola-Adefeso, William Kelley, Theodore Standiford
  • Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
    Patent number: 7696148
    Abstract: The use of leukotrienes and other products of the 5-lipoxygenase pathway to enhance bacterial defense and treat infections is described. The products are especially useful when administered to the lungs for the treatment of pneumonia and other lower respiratory tract infections. The products may be administered for treatment or prophylactic purposes and may be administered concomitantly with antibiotics to combat infection.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: April 13, 2010
    Assignee: Board of Trustees of Michigan State University
    Inventors: Marc Peters-Golden, Theodore Standiford
  • Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
    Publication number: 20050267211
    Abstract: The use of leukotrienes and other products of the 5-lipoxygenase pathway to enhance bacterial defense and treat infections is described. The products are especially useful when administered to the lungs for the treatment of pneumonia and other lower respiratory tract infections. The products may be administered for treatment or prophylactic purposes and may be administered concomitantly with antibiotics to combat infection.
    Type: Application
    Filed: January 19, 2005
    Publication date: December 1, 2005
    Inventors: Marc Peters-Golden, Theodore Standiford
  • Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
    Patent number: 5909734
    Abstract: The use of leukotrienes and other products of the 5-lipoxygenase pathway to enhance bacterial defense and treat infections is described. The products are especially useful when administered to the lungs for the treatment of pneumonia and other lower respiratory tract infections. The products may be administered for treatment or prophylactic purposes and may be administered concomitantly with antibiotics to combat infection.
    Type: Grant
    Filed: December 3, 1996
    Date of Patent: June 8, 1999
    Assignee: Regents of the University of Michigan
    Inventors: Marc Peters-Golden, Theodore Standiford